Home / Resource Library / Zanubrutinib (BGB-3111) plus obinutuzumab in patients with chronic lymphocytic leukemia and follicular lymphoma

Zanubrutinib (BGB-3111) plus obinutuzumab in patients with chronic lymphocytic leukemia and follicular lymphoma

Results of a study investigating zanubrutinib combined with obinutuzumab for follicular lymphoma and CLL.